Dianthus Therapeutics (NASDAQ:DNTH) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Dianthus Therapeutics (DNTH) operate in?

Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Dianthus Therapeutics Stock (NASDAQ: DNTH) stock price, news, charts, stock research, profile.

Open	$25.01
Close	$25.88
Volume / Avg.	3.74M / 183.69K
Day Range	23.91 - 26.18
52 Wk Range	6.58 - 33.77
Market Cap	$759.56M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	57
Short Interest	9.44%
Days to Cover	10.36

Recent News

Why Cutera Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of Cutera, Inc. (NASDAQ: CUTR) fell sharply during Friday’s session after the company reported worse-than-expected fourth quarter adjusted EPS results.

Avi Kapoor

Worthington Steel Posts Upbeat Results, Joins Summit Midstream Partners, FedEx And Other Big Stocks Moving Higher On Friday

U.S. stocks were mixed, with the Dow Jones index falling around 50 points on Friday.

Avi Kapoor

Why Dianthus Therapeutics (DNTH) Stock Is Exploding Higher

Dianthus Therapeutics shares traded higher by 37% Monday. The company announced a $230 million private placement.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Mar

Apr

May

Jun

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.3

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Dianthus Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and deliv...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dianthus Therapeutics (DNTH) stock?

You can purchase shares of Dianthus Therapeutics (NASDAQ:DNTH) through any online brokerage.

View our list of the best stock brokerages

Who are Dianthus Therapeutics (DNTH) competitors?

Other companies in Dianthus Therapeutics’s space includes: Immunome (NASDAQ:IMNM), ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE) and Sage Therapeutics (NASDAQ:SAGE).

What is the target price for Dianthus Therapeutics (DNTH) stock?

There is no analysis for Dianthus Therapeutics.

What is the forecast for Dianthus Therapeutics (DNTH) stock?

Dianthus Therapeutics has a consensus price target of $35.33.

Current stock price for Dianthus Therapeutics (DNTH)?

The stock price for Dianthus Therapeutics (NASDAQ: DNTH) is $25.88 last updated June 28, 2024 at 4:03 PM EDT.

Does Dianthus Therapeutics (DNTH) pay a dividend?

There are no upcoming dividends for Dianthus Therapeutics.

When is Dianthus Therapeutics (NASDAQ:DNTH) reporting earnings?

Dianthus Therapeutics’s Q2 earnings are confirmed for Saturday, August 3, 2024.

Is Dianthus Therapeutics (DNTH) going to split?

There is no upcoming split for Dianthus Therapeutics.

What sector and industry does Dianthus Therapeutics (DNTH) operate in?

Dianthus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Dianthus Therapeutics

Dianthus Therapeutics (DNTH) Forecast